Moderna, Merck cancer vaccine combo cuts melanoma recurrence by 44% : stocks
From Reuters:https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-merck-vaccine-combo-cut-melanoma-recurrence-by-44-study-2022-12-13/In a mid-stage trial, looks like the mRNA cancer vaccine from Moderna coupled with Merck's immuntherapy drug cut recurrence ...
